NonprofitsAdvancing Cancer Treatment

Voluntary Health Associations & Medical Disciplines

Advancing Cancer Treatment

MOULTONBORO, NH

Total revenue

$43K

Total expenses

$824K

Net assets

$679K

Grants received

$11.2M

6 grants

EIN

832886283

Tax year

2024

Mission

Acts mission is to make the washington, dc metropolitan area a leader in advancing clinical trial accrual, thus accelerating improved cancer care and treatment.

Financials

FY 2024

Revenue

Contributions & grants
Program service revenue
Investment income$43K
Other revenue
Total revenue$43K

Expenses

Grants paid$348K
Salaries & benefits
Fundraising$2K
Other expenses$476K
Total expenses$824K
Total assets$714K
Net assets$679K

People

7 listed

NameRoleCompensation

OTIS W BRAWLEY MD

DIRECTOR

Board

0.2 hrs/wk

ROBERT L GROSSMAN

DIRECTOR

Board

0.2 hrs/wk

JEANNY B ARAGON-CHING MD

DIRECTOR

Board

0.2 hrs/wk

DONALD L TRUMP MD

DIRECTOR

Board

0.2 hrs/wk

ADAM R METWALLI MD

DIRECTOR

Board

0.2 hrs/wk

PAMELA BROWN

VICE PRESIDENT, SECRETARY

Board

0.2 hrs/wk

DAVID BROWN

PRESIDENT, TREASURER

Board

0.2 hrs/wk

Independent contractors

JENNY CHIANG ED CONS LLC

CONSULTING

$122K

Grants received

Showing 6 of 6

FromAmountPurposeYear
$4M
For grant recipient's exempt purposes
2022
$2.5M
For grant recipient's exempt purposes
2021
$2.5M
For grant recipient's exempt purposes
2021
$800K
For grant recipient's exempt purposes
2020
$800K
For grant recipient's exempt purposes
2019
$600K
For grant recipient's exempt purposes
2018

Funded by

$11.2M from 1 funder · 6 grants · 2018–2022

Fidelity Investments Charitable Gift Fund

$11.2M · 6 grants · 2018–2022

Details

EIN832886283
NTEE codeG12
Subsection03
Ruling date2019-02
Formed2018
Employees0
Volunteers7
ADVANCING CANCER TREATMENT — Mission, Financials & Grants Received | Grantivo